Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation

Transfus Med. 2014 Jun;24(3):187-8. doi: 10.1111/tme.12121. Epub 2014 May 9.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Blood Group Incompatibility / complications
  • Blood Group Incompatibility / drug therapy*
  • Blood Group Incompatibility / pathology
  • Boronic Acids / administration & dosage*
  • Bortezomib
  • Humans
  • Injections, Subcutaneous
  • Male
  • Middle Aged
  • Pyrazines / administration & dosage*
  • Red-Cell Aplasia, Pure / drug therapy*
  • Red-Cell Aplasia, Pure / etiology
  • Red-Cell Aplasia, Pure / pathology

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib